Free University of Brussels
Also known as: Academisch Ziekenhuis der Vrije Universiteit Brussel | AZ-VUB | AZ VUB Brussels | AZ VUB, Brussels | Bordet Institute, Brussels | Br.E.A.S.T. -Data Center & Operational Office Institut Jules Bordet | Brugmann University Hospital | Brugmann University Hospital, Free University of Brussels | Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Belgium | Centre Hospitalier Universitaire Brugmann | Centre Hospitalier Universitaire (CHU) Brugmann | Centre Hospitalier Universitaire Saint Pierre | CHU Saint-Pierre, Brussels, Belgique | CHU saint Pierre de Bruxelle | CHU St-Pierre | CHU ST Pierre | Clinique Saint Pierre Ottignies | Clinique Saint Pierre - Ottignies -Belgium | Clinique Saint Pierre, Ottignies, Belgium | Committee of Medical Ethics University Hospital University of Brussels, B.U.N. 143201627110. | CRG UZ Brussel | Department of Nephrology, University Hospital Brussels | Director Innovation Clinic, Erasmus Academical Hospital, Université Libre de Bruxelles, Belgium and Silesian Medical University, Poland | Emma Rheel, Ph.d. Vrije Universiteit Brussel | Erasme Hospital, ULB | Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium | Erasmuc MC | Eric Durand | Fabiola Soares Moreira Campos | Free University of Brussels | Gerontology department (GERO) and Frailty in Ageing (FRIA) research department, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, B-1090 Brussels, Belgium | Haute Ecole Lucia De Brouckère | Hôpital Erasme, Université Libre de Brussels, Brussels, Belgium | Hospital Erasme | Hospital Erasme, Brussels, Belgium | Insitut Jules Bordet | Institute Jules Bordet | Institut Jules Bordet, Brussels | Institut Jules Bordet, Brussels, Belgium | Institut Jules Bordet, Bruxelles, Belgium - LYSA | Institut Jules Bordet - Medical Oncology and Translational Research | Jules Bordet Insitute | Jules Bordet Institut | Jules Bordet Institute | Jules Bordet Institute, Brussels, Belgium | Kelly Ickmans, Ph.d. Vrije Universiteit Brussel | Master student in Medicine at Vrije Universiteit Brussel | Moens Maarten | mohamed_bali@stpierre-bru.be | Public Private Partnership with Institute for Medical Immunology (Universite Libre de Bruxelles) | Queen Fabiola Children's University Hospital | Resident of department of Anesthesiology | Salvatore Campanella | Serge Rozenberg | stichting tegen kanker | Surgeon in Jules Bordet Institute | ULB | Universitair Ziekenhuis Brussel | Universitair Ziekenhuis Brussel, Belgium | Université Libre de Bruxelles | University Hospital Brussel | University Hospital Brussels, Belgium | University Hospital Erasme, Brussels, Belgium | University Hospital Saint-Pierre (CHU Saint-Pierre) | University Hospital Saint-Pierre (CHU Saint-Pierre), Universite libre de Bruxelles (ULB) | University Hospital Saint-Pierre (CHU Saint-Pierre), Université Libre de Bruxelles (ULB) | University hospital St-luc, Brussel | University of Brussels, faculty of Rehabilitation science and physical therapy, faculty of Pharmacy and medicine, Brussels, Belgium | UZ Brussel, Centre for Reproductive Medicine, Brussels | UZ Brussels | UZ Brussel - Vrije Universiteit Brussel | UZ Brussel (Vrije Universiteit Brussel) | Vrije Universiteit Brussel | Vrije Universiteit Brussel - Alexianen Zorggroep Tienen | Vrije Universiteit Brussel - Ghent University | Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel | VUB
Highest phase reached
Phase 4
First clinical trial
Aug 1, 1998Last known activity
Jul 24, 2025
Timeline
1830s
- Jan 1, 1834
Free University of Brussels— Founded
Drugs by trial phase (263 distinct, 276 trials)
Phase 4 (66 own, 0 via acquisition)
Phase 3 (54 own, 0 via acquisition)
Phase 2 (93 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Other trials (37 own, 0 via acquisition)
Indications
Studied for
- Abortion, Spontaneous
- Acute Pain
- Adenocarcinoma
- Adenocarcinoma, Bronchiolo-Alveolar
- Agnosia
- Alcoholism
- Anemia, Sickle Cell
- Anxiety Disorders
- Asthma
- Ataxia
- Bacterial Infections
- Behavior, Addictive
- Beriberi
- Bile Reflux
- Brain Diseases
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Lobular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cerebellar Ataxia
- Cholangiocarcinoma
- Cocaine-Related Disorders
- Colorectal Neoplasms
- Communicable Diseases
- Congenital Abnormalities
- Crohn Disease
- Cystic Fibrosis
- Cystinuria
- Deafness
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Emergencies
- Empyema
- Empyema, Pleural
- Endometrial Neoplasms
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Esophagitis
- Esophagitis, Peptic
- Febrile Neutropenia
- Fibrosis
- Friedreich Ataxia
- Gastroesophageal Reflux
- Genital Diseases, Female
- Genital Diseases, Male
- Glioblastoma
- Glomerulosclerosis, Focal Segmental
- Graft vs Host Disease
- Gram-Positive Bacterial Infections
- Hand-Foot Syndrome
- Head and Neck Neoplasms
- Hearing Loss
- Hearing Loss, Bilateral
- Hemolysis
- Hepatitis
- Hepatitis A
- Hepatitis B
- HIV Infections
- Hodgkin Disease
- Hyperalgesia
- Hyperlactatemia
- Hyperoxaluria
- Hypotension
- Infections
- Infertility
- Infertility, Female
- Influenza, Human
- Kidney Calculi
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Marijuana Abuse
- Melanoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Neoplastic Cells, Circulating
- Nephrolithiasis
- Nephrosis
- Nephrosis, Lipoid
- Nephrotic Syndrome
- Neuroendocrine Tumors
- Neutropenia
- Oropharyngeal Neoplasms
- Osteoporosis
- Ovarian Neoplasms
Recent trials (50)
- NCT06992141CollaboratorEarly Phase 1Jul 24, 2025
- NCT06595563OfficialPhase 2Jan 31, 2025
- NCT06595563Lead sponsorPhase 2Jan 31, 2025
- NCT06666101Sponsor investigatorN/ANov 4, 2024
- NCT06666101Lead sponsorN/ANov 4, 2024
- NCT06411301Lead sponsorPhase 1Oct 31, 2024
- NCT06150898Study chairPhase 2Feb 20, 2024
- NCT06150898Lead sponsorPhase 2Feb 20, 2024
- NCT06227338OfficialN/AFeb 12, 2024
- NCT06227338Lead sponsorN/AFeb 12, 2024
- NCT06387862OfficialPhase 2Feb 1, 2024
- NCT06387862Lead sponsorPhase 2Feb 1, 2024
- NCT06160232Lead sponsorPhase 2Jan 15, 2024
- NCT06160232Reponsible party - principal investigatorPhase 2Jan 15, 2024
- NCT06160232OfficialPhase 2Jan 15, 2024
Details
- Founded
- Brussels, BE Jan 1, 1834
- Last known activity
- Jul 24, 2025